BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30390063)

  • 1. The role of stem cell transplantation in the management of relapsed follicular lymphoma in the era of targeted therapies.
    Norman JE; Schouten HC; Dreger P; Robinson SP
    Bone Marrow Transplant; 2019 Jun; 54(6):787-797. PubMed ID: 30390063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and outcomes of relapsed follicular lymphoma after autologous stem cell transplantation in the rituximab era.
    Sesques P; Bourcier J; Golfier C; Lebras L; Nicolas-Virelizier E; Hacini M; Perrin MC; Voillat L; Bachy E; Traverse-Glehen A; Moreau A; Martin L; Ramla S; Casasnovas O; Le Gouill S; Salles G; Ghesquières H
    Hematol Oncol; 2020 Apr; 38(2):137-145. PubMed ID: 31953963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel immunotherapy approaches to follicular lymphoma.
    Flowers CR; Leonard JP; Nastoupil LJ
    Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):194-199. PubMed ID: 30504310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: a comprehensive analysis from the NCCN lymphoma outcomes project.
    Evens AM; Vanderplas A; LaCasce AS; Crosby AL; Nademanee AP; Kaminski MS; Abel GA; Millenson M; Czuczman MS; Rodriguez MA; Niland J; Zelenetz AD; Gordon LI; Friedberg JW
    Cancer; 2013 Oct; 119(20):3662-71. PubMed ID: 23921646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating relapsed follicular lymphoma.
    Erblich T; Montoto S
    Expert Rev Hematol; 2018 May; 11(5):403-410. PubMed ID: 29542329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR.
    Sureda A; Zhang MJ; Dreger P; Carreras J; Fenske T; Finel H; Schouten H; Montoto S; Robinson S; Smith SM; Boumedil A; Hamadani M; Pasquini MC
    Cancer; 2018 Apr; 124(8):1733-1742. PubMed ID: 29424927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of idelalisib as bridge to allogeneic stem cell transplant in relapsed follicular lymphoma: a case report.
    Marangon M; Pellegrini C; Argnani L; Zinzani PL
    Tumori; 2017 Nov; 103(Suppl. 1):e41-e43. PubMed ID: 28967090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab purging and/or maintenance in patients undergoing autologous transplantation for relapsed follicular lymphoma: a prospective randomized trial from the lymphoma working party of the European group for blood and marrow transplantation.
    Pettengell R; Schmitz N; Gisselbrecht C; Smith G; Patton WN; Metzner B; Caballero D; Tilly H; Walewski JA; Bence-Bruckler I; To B; Geisler CH; Schots R; Kimby E; Taverna CJ; Kozák T; Dreger P; Uddin R; Ruiz de Elvira C; Goldstone AH
    J Clin Oncol; 2013 May; 31(13):1624-30. PubMed ID: 23547078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-grade lymphoma.
    Winter JN; Gascoyne RD; Van Besien K
    Hematology Am Soc Hematol Educ Program; 2004; ():203-20. PubMed ID: 15561684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential benefit of allogeneic over autologous transplantation in patients with very early relapsed and refractory follicular lymphoma with prior remission duration of ≤12 months.
    Lunning MA; Migliacci JC; Hilden P; Devlin SM; Castro-Malaspina H; Giralt S; Perales MA; Zelenetz AD; Moskowitz CH; Sauter CS
    Br J Haematol; 2016 Apr; 173(2):260-4. PubMed ID: 26847389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of stem cell transplantation in the treatment of follicular lymphoma.
    Finke J
    Semin Cancer Biol; 2003 Jun; 13(3):233-9. PubMed ID: 12959354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of transformed follicular lymphoma worsens according to the timing of transformation and to the number of previous therapies. A retrospective multicenter study on behalf of Fondazione Italiana Linfomi (FIL).
    Rusconi C; Anastasia A; Chiarenza A; Marcheselli L; Cavallo F; Rattotti S; Botto B; Ferrari A; Nassi L; Pagani C; Meli E; Arcaini L; Federico M; Rossi G;
    Br J Haematol; 2019 May; 185(4):713-717. PubMed ID: 30793297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.
    Schaaf M; Reiser M; Borchmann P; Engert A; Skoetz N
    Cochrane Database Syst Rev; 2012 Jan; 1():CD007678. PubMed ID: 22258971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When to treat patients with relapsed follicular lymphoma.
    Cheah CY; Seymour JF
    Expert Rev Hematol; 2017 Mar; 10(3):187-191. PubMed ID: 28164722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous transplantation in patients with relapsed or high-grade follicular lymphoma provides long term disease-free survival and best median duration of response.
    Ganguly S; Divine CL; Deauna-Limayo D; Bodensteiner DC; Cook JD; Lewis JN; Skikne BS
    Ann Hematol; 2005 Aug; 84(8):526-31. PubMed ID: 15915350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT.
    Robinson SP; Canals C; Luang JJ; Tilly H; Crawley C; Cahn JY; Pohlreich D; Le Gouill S; Gilleece M; Milpied N; Attal M; Biron P; Maury S; Rambaldi A; Maertens J; Capria S; Colombat P; Montoto S; Sureda A
    Bone Marrow Transplant; 2013 Nov; 48(11):1409-14. PubMed ID: 23771004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab maintenance after autologous stem cell transplantation prolongs response duration in non-naive rituximab follicular lymphoma patients: a single institution experience.
    Bourcier J; Gastinne T; Leux C; Moreau A; Bossard C; Mahé B; Blin N; Dubruille V; Touzeau C; Voldoire M; Guillaume T; Peterlin P; Gallas P; Garnier A; Maisonneuve H; Moreau P; Juge-Morineau N; Jardel H; Chevallier P; Moreau P; Le Gouill S
    Ann Hematol; 2016 Aug; 95(8):1287-93. PubMed ID: 27297970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current therapeutic strategies and new treatment paradigms for follicular lymphoma.
    Kritharis A; Sharma J; Evens AM
    Cancer Treat Res; 2015; 165():197-226. PubMed ID: 25655611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How I treat early-relapsing follicular lymphoma.
    Casulo C; Barr PM
    Blood; 2019 Apr; 133(14):1540-1547. PubMed ID: 30700421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of stem cell transplantation in follicular lymphoma.
    Hess G
    Best Pract Res Clin Haematol; 2018 Mar; 31(1):31-40. PubMed ID: 29452664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.